small molecule

MINOXIDIL (FOR WOMEN)

MINOXIDIL

Loss of exclusivityloss of exclusivity
CompanyTaro Pharmaceutical IndustriesSee this company's full patent-cliff portfolio

Drug detail

Brand nameMINOXIDIL (FOR WOMEN)
Active ingredientMINOXIDIL
Strength5%
Dosage formAEROSOL, FOAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalApril 2019
Marketing statusOTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MINOXIDIL (FOR WOMEN) patent cliff — loss of exclusivity — | CliffBio